← Back to All Filings

Intuitive Surgical EVP Mark Brosius Sells $24.7K in Common Stock Under Rule 10b5-1 Plan

Low SignificanceSeptember 10, 2026 at 12:10:52 PM EDT

INTUITIVE SURGICAL INC

$ISRG4CIK: 0001035267

Subscribe to track ISRG

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

# Insider Trade Alert: INTUITIVE SURGICAL INC ($ISRG)
**Insider**: Brosius Mark (EVP & Chief Mfg and Supply Cha)
**Action**: Sale (Rule 10b5-1)
**Shares Sold**: 69
**Average Price**: $357.55
**Total Value**: $24,671.18
**Shares Held After**: 812
**Filing Date**: 2026-09-09

Comprehensive Analysis

Insider Trading Summary: INTUITIVE SURGICAL INC ($ISRG)

Overview

On September 9, 2026, Mark Brosius, Executive Vice President & Chief Manufacturing and Supply Chain Officer of Intuitive Surgical Inc. ($ISRG), reported the open market sale of 69 shares of Common Stock across two transactions pursuant to a pre-arranged Rule 10b5-1 trading plan.

Transaction Details

  • September 8, 2026: Disposed of 46 shares at an average price of $361.23 per share ($16,616.58).
  • September 9, 2026: Disposed of 23 shares at an average price of $350.20 per share ($8,054.60).
  • Combined Shares Sold: 69 shares
  • Total Gross Proceeds: $24,671.18
  • Post-Transaction Holdings: 812 shares held directly.

Key Takeaways

  • Trading Plan: Transactions were executed pursuant to an SEC Rule 10b5-1 trading plan expiring on February 14, 2027.
  • Market Impact: Minimal significance due to the low transaction volume ($24.7K) and routine nature of pre-scheduled 10b5-1 trading plans.
Topics:#ISRG#IntuitiveSurgical#InsiderTrading#StockMarket#Form4

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.